Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Virtual Preceptorship on Immuno-Oncology 2020: December

Name: ESMO Virtual Preceptorship on Immuno-Oncology 2020: December
Start: 2020-12-15T23:00:00+00:00
End: 2020-12-17T22:59:00+00:00
Location: ESMO Virtual Preceptorship on Immuno-Oncology 2020: December

ESMO Virtual Preceptorship on Immuno-Oncology 2020 December 1000x250px

Start date: 16 Dec 2020
End date: 17 Dec 2020
Location: Virtual, CET Time

Please kindly note that the virtual course programme timings are to be considered CET (Central European Time)

Learning objectives

To understand the basics of tumour immunology
To learn about the essentials of immunotherapies and their applications in cancer medicine
To learn about the status of development and clinical experience of immunotherapy in different tumour types

Download the programme

How to apply

Application is via online form. During the application process you will be required to upload the following:

Your CV including a list of your publications

3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)

Application deadline

Applications for the online course are now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

John B.A.G. Haanen, Netherlands
Solange Peters, Switzerland
Rolf A. Stahel, Switzerland